Thu, Aug 21, 2014, 3:40 PM EDT - U.S. Markets close in 20 mins.

Recent

% | $
Quotes you view appear here for quick access.

Threshold Pharmaceuticals Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • tredleon tredleon Apr 11, 2007 1:14 PM Flag

    Erbitux fails...

    I always believed there was a better chance of success in the current P2 trial (in combination with Gemzar) than the recently failed P3 trial (end-stage for those who failed first-line Gemzar therapy), but bought a small position in the fall of last year anyway. I'm still trying to decide whether I want to add to my position - the preliminary P2 results are showing good "objective response", but survival is the only thing that matters, and there may not be much of a connection between shrinking/halting the growth of tumors and extending patients lives? But I keep thinking that the bar is so low (even a 2-3 month impact on survival would be significant) that Glufo just might pull it off. This one is definitely a crapshoot, but if it helps in pancreatic cancer, I think it will most likely be successful as a combination agent in other solid tumor treatments, so there is good upside potential.

 
THLD
4.10+0.02(+0.49%)3:40 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.